2020 ISPE Europe Biotechnology Virtual Conference

How ATMPs, Aseptics and Drug Products Meet Digitalisation

We continue to monitor the unfolding global impact of COVID-19, and as the world evolves, so do we. We are transforming this event to be fully digital.


Biologics continue to develop into the most important group of medical drugs in the future. The market share value is steadily growing, new therapeutic approaches offer new possibilities to more successful treatment of severe diseases.

In Amsterdam, the new location for the European Medicines Agency, this October, ISPE will continue the series of successful biotechnology conferences featuring the 2020 ISPE Europe Biotechnology Conference. Case studies will be presented, from concepts to industrialisation. Plant tours to new, state-of-the-art facilities will be offered, and the conference will be followed by a workshop where current industry practise and new ways of operations, e.g.

  • How to build a Contamination Control Strategy to prevent product contamination during the process?
  • How to design a facility, workshop to make ATMP’s with manual aseptic processes and avoiding product contamination during production?

In particular, the group of Advanced Therapy Medicinal Products (ATMPs) have particular GMP regulations linked to Annex 2 from PIC/S. “How to ensure that the GMP requirements for the manufacturing of biologics are met?” is one of the most important questions asked when companies invest in manufacturing facilities. The conference will highlight the differences between EC GMP Guide and the Annex 2 from PIC/S.

New technology platforms and the wave of digitisation will open innovative ways for process analysis, process verification and overall process control. The ISPE Pharma 4.0 approach will demonstrate elements and enablers but also roadmaps for implementation in biological manufacturing.

Data science - and process science concepts are key enablers for stable processes and a premise for continuous product supply. The conference will focus on how this can be successfully achieved.

Topics Include

  • Hear what the new megatrends are and how it will influence your operations and shape the future
  • Discover professional ideas on how to develop a contamination control strategy to prevent product contamination
  • Explore expert ways to ensure that the GMP requirements for manufacturing of biologics are met
  • Learn what industry leaders’ thoughts are for tomorrow
  • Engage with Regulators addressing the regulatory framework for biologics
  • Learn from the challenges in manufacturing personalised medicines
  • Network with colleagues and speakers to learn about best practice ideas and influencer

Why Attend Virtually

  • Feel like You're In-Person with a Fully Interactive Digital Experience
    Our event portal is easy to navigate and will allow you to view presentations, access PDFs of the presentations, take downloadable notes in each session, participate in polls, chat with other attendees, and participate in LIVE Q&A sessions with speakers.
    alt 1
  • Build Your Experience
    Add the sessions you want to attend with the click of a button to build your own custom agenda. Interested in two sessions happening at the same? We have you covered because you'll have access to all of the recordings from the event for one year.
    alt 2
  • Gain Actionable Insights
    Global experts will be at your fingertips sharing their knowledge and lessons learned on advanced therapeutic medicinal products (ATMPs) including cell and gene therapies, digitalization, single-use technology, implications of ICH Q12 for biopharma, and much more.
    alt 3
  • Stay Current and Knowledgeable Throughout the Year
    In addition to expert insights, your tangible takeaways include access to the recording of ALL conference sessions and presentations for one year. Unlike an in-person event, you’ll get to experience the sessions you missed—that means both tracks! The recordings are also valuable as a refresher throughout the year.
    alt  4

Virtual Event FAQs


Who Should Attend?

Professionals at all levels of the pharmaceutical industry including:

Young Professionals Senior Executives Communities of Practice Special Interest Groups Equipment and Services Suppliers Regulatory Professionals